drug
interferon alfa-2b
Marketedupdated 3mo agoby Schering-Plough Corp (Inactive)
Approvedcommunity read0 votes
indications
investigational
MelanomaDLBCL
all catalysts(0)
nothing on the calendar yet
Trials studying interferon alfa-2b
- phase3A Clinical Trial of Bomedemstat in Participants With Polycythemia Vera (MK-3543-025)
- phase3Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance
- phase2Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery
- phase1Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL)
- phase2Ropeginterferon Alfa-2b for the Treatment of Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes and Chronic Myelomonocytic Leukemia
- phase2Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients
- phase3Efficacy and Safety of MP-424, Peginterferon Alfa-2b, and Ribavirin in Patients With Chronic Hepatitis C Who Relapsed After Previous Interferon Based Therapy
- phase3Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Relapser Genotype 2 Hepatitis C Infected Patients
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 40m ago
Found something off?
comments(0)
5-min edit window · permanent after that